v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Balance at beginning of period (in shares) at Dec. 30, 2023   78,311        
Balance at beginning of period at Dec. 30, 2023 $ 829,418 $ 848 $ 788,967 $ (419) $ 254,616 $ (214,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares) [1]   363        
Issuance of common stock [1] 316 $ 4 312      
Stock-based compensation 2,431   2,431      
Purchase of treasury stock (in shares)   (116)        
Purchase of treasury stock (2,721)         (2,721)
Unrealized gain on hedge instruments, net of tax 190     190    
Net income (loss) 11,685       11,685  
Balance at end of period (in shares) at Mar. 30, 2024   78,558        
Balance at end of period at Mar. 30, 2024 841,319 $ 852 791,710 (229) 266,301 (217,315)
Balance at beginning of period (in shares) at Dec. 30, 2023   78,311        
Balance at beginning of period at Dec. 30, 2023 829,418 $ 848 788,967 (419) 254,616 (214,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 8,560          
Balance at end of period (in shares) at Jun. 29, 2024   78,628        
Balance at end of period at Jun. 29, 2024 843,408 $ 853 796,812 (64) 263,176 (217,369)
Balance at beginning of period (in shares) at Mar. 30, 2024   78,558        
Balance at beginning of period at Mar. 30, 2024 841,319 $ 852 791,710 (229) 266,301 (217,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares) [1]   73        
Issuance of common stock [1] 354 $ 1 353      
Stock-based compensation 4,749   4,749      
Purchase of treasury stock (in shares)   (3)        
Purchase of treasury stock (54)         (54)
Unrealized gain on hedge instruments, net of tax 165     165    
Net income (loss) (3,125)       (3,125)  
Balance at end of period (in shares) at Jun. 29, 2024   78,628        
Balance at end of period at Jun. 29, 2024 $ 843,408 $ 853 796,812 (64) 263,176 (217,369)
Balance at beginning of period (in shares) at Dec. 28, 2024 78,775 78,775        
Balance at beginning of period at Dec. 28, 2024 $ 816,333 $ 854 807,048 0 226,117 (217,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares) [2]   403        
Issuance of common stock [2] 265 $ 4 261      
Stock-based compensation 7,000   7,000      
Purchase of treasury stock (in shares)   (128)        
Purchase of treasury stock (1,624)         (1,624)
Unrealized gain on hedge instruments, net of tax 0          
Net income (loss) 14,186       14,186  
Balance at end of period (in shares) at Mar. 29, 2025   79,050        
Balance at end of period at Mar. 29, 2025 $ 836,160 $ 858 814,309 0 240,303 (219,310)
Balance at beginning of period (in shares) at Dec. 28, 2024 78,775 78,775        
Balance at beginning of period at Dec. 28, 2024 $ 816,333 $ 854 807,048 0 226,117 (217,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 22,911          
Balance at end of period (in shares) at Jun. 28, 2025 79,175 79,175        
Balance at end of period at Jun. 28, 2025 $ 850,581 $ 859 820,059 0 249,028 (219,365)
Balance at beginning of period (in shares) at Mar. 29, 2025   79,050        
Balance at beginning of period at Mar. 29, 2025 836,160 $ 858 814,309 0 240,303 (219,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares) [2]   130        
Issuance of common stock [2] 471 $ 1 470      
Stock-based compensation 5,280   5,280      
Purchase of treasury stock (in shares)   (5)        
Purchase of treasury stock (55)         (55)
Unrealized gain on hedge instruments, net of tax 0          
Net income (loss) $ 8,725       8,725  
Balance at end of period (in shares) at Jun. 28, 2025 79,175 79,175        
Balance at end of period at Jun. 28, 2025 $ 850,581 $ 859 $ 820,059 $ 0 $ 249,028 $ (219,365)
[1]
(1) Consists primarily of the vesting of shares issued under the Company’s stock incentive plans and Associate Share Purchase Plan.
[2]
(1) Consists primarily of the vesting of shares issued under the Company’s stock incentive plans and Associate Share Purchase Plan.